2023
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
Krystal J, Kaye A, Jefferson S, Girgenti M, Wilkinson S, Sanacora G, Esterlis I. Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments. Proceedings Of The National Academy Of Sciences Of The United States Of America 2023, 120: e2305772120. PMID: 38011560, PMCID: PMC10710048, DOI: 10.1073/pnas.2305772120.Peer-Reviewed Original Research
2015
Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder.
Wilkinson ST, Stefanovics E, Rosenheck RA. Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder. The Journal Of Clinical Psychiatry 2015, 76: 1174-80. PMID: 26455669, PMCID: PMC6258013, DOI: 10.4088/jcp.14m09475.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderPTSD symptomsSymptom severityPTSD symptom severityWorse outcomesObservational studyMarijuana useStress disorderAlcohol useRelevant baseline covariatesWorse PTSD symptomsEffect sizeViolent behaviorBaseline characteristicsIntensive treatmentPrevention of useMeasures of alcoholAnalysis of covarianceDrug useAdmissionBaseline covariatesSymptomsTreatment programRelevant covariatesMedical marijuana